Nav: Home

Poor ability to slow heart rate predicts death after heart attack

May 18, 2006

Heart attack survivors who lack variability in their heart rate are at a greater risk of death, according to a paper in this week's issue of The Lancet. The study found that measuring the ability of the heart rate to slow down (heart rate deceleration capacity) was a better predictor of mortality after heart attack than current measures.

Studies suggest that the risk of death in patients who have had a heart attack can be reduced by implantation of a defibrillator. The gold-standard measure used to predict risk of death is the extent of impairment of the left-ventricle of the heart.

Georg Schmidt (Munich University of Technology, Munich, Germany) and colleagues investigated an alternative measure - heart rate deceleration capacity. A person's heart rate is not perfectly regular but varies with the breathing cycle, speeding with inspiration and slowing down on exhalation. Heart rate can also speed up with decreasing arterial pressure and slow down with increasing arterial pressure. The capacity of the heart rate to vary is a marker for wellbeing.

By analysing data from 2,700 patients who had had a heart attack the investigators found that heart-rate deceleration capacity was a stronger predictor of mortality than the left ventricle impairment measure or standard measures of heart rate variability.

Professor Schmidt states: "Deceleration capacity substantially improves risk prediction in survivors of acute myocardial infarction [heart attack]...Our findings show that this new measure can detect high-risk patients even if the current gold-standard measure fails."

See also accompanying Comment.
-end-
Contact: Georg Schmidt, MD, Professor of Cardiology, Technische Universität München 1, Medizinische Klinik, Klinikum r.d.Isar, Ismaninger Str. 22, 81675, Munich, Germany. T) +49 89 41402352 gschmidt@tum.de

Lancet

Related Heart Attack Articles:

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.
New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.
Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.
A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.
Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.
Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.
Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.
How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.
Heart attack patients taken directly to heart centers have better long-term survival
Heart attack patients taken directly to heart centers for lifesaving treatment have better long-term survival than those transferred from another hospital, reports a large observational study presented today at Acute Cardiovascular Care 2019, a European Society of Cardiology congress.
Among heart attack survivors, drug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.
More Heart Attack News and Heart Attack Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.